http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-1243971-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_db7324dd156e7b5744b5c160e3f02ccf |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P19-38 |
| filingDate | 1986-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1988-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_56a678008ddffd89251194a36626a8e9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd05548b18459ef17e80f1d40281d031 |
| publicationDate | 1988-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CA-1243971-A |
| titleOfInvention | Method for producing cytidine monophosphate of 5- acetamido-3,5-dideoxy-d-glycero-d- galactononulosaminic acid |
| abstract | ABSTRACT OF THE DISCLOSURE Cytidine monophosphate of 5-acetamido-3,5-dideoxy-D-glycero-D-galactononulosaminic acid is produced by an improved method by the condensation of cytidine triphosphate (CTP) with N-acetylneuraminic acid (NANA), catalyzed by the enzyme CMP-transferase (CMP-acylneuraminate synthase) (EC 2.7.7.43), either (A) in the presence of a thiocarboxylic acid or nitro-imidazole stabilizer or (B) using the enzyme isolated from the E. coli strain CRC 1482. The product can be used as an active substance in pharmaceutical compositions for use in the therapy of pathological states related to disturbances of the nervous stimulus in the central (CNS) and peripheral (PNS) nervous system. |
| priorityDate | 1983-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 66.